ZA201201471B - Nutritional compositions for breast-fed infants or pets with probiotics and selected nutrients - Google Patents

Nutritional compositions for breast-fed infants or pets with probiotics and selected nutrients

Info

Publication number
ZA201201471B
ZA201201471B ZA2012/01471A ZA201201471A ZA201201471B ZA 201201471 B ZA201201471 B ZA 201201471B ZA 2012/01471 A ZA2012/01471 A ZA 2012/01471A ZA 201201471 A ZA201201471 A ZA 201201471A ZA 201201471 B ZA201201471 B ZA 201201471B
Authority
ZA
South Africa
Prior art keywords
probiotics
pets
breast
nutritional compositions
fed infants
Prior art date
Application number
ZA2012/01471A
Other languages
English (en)
Inventor
Degonda Gabriela Bergonzelli
Clara Lucia Garcia-Rodenas
Isabelle Bureau-Franz
Corinne Magliola
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41259077&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201201471(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of ZA201201471B publication Critical patent/ZA201201471B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A23K50/48—Moist feed
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Birds (AREA)
  • Obesity (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pediatric Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Oncology (AREA)
ZA2012/01471A 2009-07-31 2012-02-28 Nutritional compositions for breast-fed infants or pets with probiotics and selected nutrients ZA201201471B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09166969 2009-07-31
PCT/EP2010/060973 WO2011012655A1 (en) 2009-07-31 2010-07-28 Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients

Publications (1)

Publication Number Publication Date
ZA201201471B true ZA201201471B (en) 2014-08-27

Family

ID=41259077

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2012/01471A ZA201201471B (en) 2009-07-31 2012-02-28 Nutritional compositions for breast-fed infants or pets with probiotics and selected nutrients

Country Status (14)

Country Link
US (1) US20120121562A1 (https=)
EP (1) EP2459202A1 (https=)
CN (1) CN102481323A (https=)
AU (1) AU2010277582A1 (https=)
BR (1) BR112012002223A2 (https=)
CA (1) CA2767960A1 (https=)
CL (1) CL2012000234A1 (https=)
IN (1) IN2012DN00282A (https=)
MX (1) MX2012001362A (https=)
RU (1) RU2012107695A (https=)
SG (1) SG177541A1 (https=)
TW (1) TW201117818A (https=)
WO (1) WO2011012655A1 (https=)
ZA (1) ZA201201471B (https=)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3338784B1 (en) 2010-12-31 2020-07-22 Abbott Laboratories Human milk oligosaccharides for modulating inflammation
WO2012092157A2 (en) 2010-12-31 2012-07-05 Abbott Laboratories Nutritional formulations including human milk oligosaccharides and antioxidants and uses thereof
MY197622A (en) 2010-12-31 2023-06-28 Abbott Lab Methods for decreasing the incidence of necrotizing enterocolitis in infants, toddlers, or children using human milk oligosaccharides
ES2708924T3 (es) 2010-12-31 2019-04-12 Abbott Lab Procedimientos de uso de oligosacáridos de la leche humana para mejorar la salud respiratoria de las vías respiratorias
BR112013015951A2 (en) 2010-12-31 2018-07-10 Abbott Laboratories nutritional compositions comprising human milk oligosaccharides and nucleotides and uses thereof to treat and / or prevent enteric viral infection.
US11337990B2 (en) 2010-12-31 2022-05-24 Abbott Laboratories Human milk oligosaccharides to promote growth of beneficial bacteria
MY180910A (en) 2010-12-31 2020-12-11 Abbott Lab Methods for reducing the incidence of oxidative stress using human milk oligosaccharides, vitamin c and anti-inflammatory agents
CN102106463B (zh) * 2011-01-31 2012-12-05 杨永浩 一种微生物饲料添加剂及其制备方法
CA2825697A1 (en) * 2011-02-10 2012-08-16 Nestec S.A. Modulation of growth of bifidobacteria using a combination of oligosaccharides found in human milk
ITMI20111488A1 (it) * 2011-08-03 2013-02-04 Gnosis Spa Formulazioni comprendenti saccharomyces boulardii e superossido dismutasi (sod) per controllare l'obesita'
SG2014013478A (en) 2011-08-29 2014-05-29 Abbott Lab Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
ES2601891T3 (es) * 2011-10-18 2017-02-16 Nestec S.A. Composición para su uso en crecimiento cerebral y/o desarrollo cognitivo y/o psicomotor
US20140286908A1 (en) * 2011-10-18 2014-09-25 Nestec S.A. Composition for use in the promotion of intestinal angiogenesis and of nutrient absorption and of enteral feeding tolerance and/or in the prevention and/or treatment of intestinal inflammation and/or in the recovery after intestinal injury and surgery
KR101166798B1 (ko) * 2011-12-19 2012-07-26 김대현 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물
UA118339C2 (uk) * 2012-09-03 2019-01-10 Біогайа Аб Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
US9987306B2 (en) 2012-10-15 2018-06-05 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
US11179427B2 (en) 2013-01-21 2021-11-23 Eth Zurich Baby food composition comprising viable propionic acid-producing bacteria
EP3128859A1 (en) 2014-03-26 2017-02-15 Abbott Laboratories Nutritional supplement powder
WO2015176229A1 (en) * 2014-05-20 2015-11-26 Nestle (China) Ltd. Delivery mode specific synthetic nutritional compositions and nutritional systems comprising them
ES3004085T3 (en) * 2015-03-05 2025-03-11 Nestle Sa Compositions for use in improving stool consistency or frequency in infants or young children
WO2016183535A1 (en) 2015-05-14 2016-11-17 University Of Puerto Rico Methods for restoring microbiota of newborns
CN105030843A (zh) * 2015-06-18 2015-11-11 陈英扬 罗伊氏乳杆菌滴剂及其制备方法
JP2018528938A (ja) * 2015-08-31 2018-10-04 ネステク ソシエテ アノニム 情動的反応を制御するため、並びに潜在的な気分変調の治療及び予防のための、ビフィドバクテリウム・ロンガムを用いる、方法及び組成物
MX2018006295A (es) * 2015-12-14 2018-08-16 Nestec Sa Composicion nutritiva y formula infantil para promover la mielinizacion del cerebro.
WO2017117142A1 (en) 2015-12-28 2017-07-06 New York University Device and method of restoring microbiota of newborns
WO2017151540A1 (en) 2016-02-29 2017-09-08 Abbott Laboratories Nutritional supplement powder
KR101938865B1 (ko) * 2016-11-03 2019-01-16 주식회사 쎌바이오텍 골 질환, 비만 및 지질 관련 대사성 질환의 예방 또는 치료용 조성물
US20200108084A1 (en) * 2017-05-24 2020-04-09 Societe Des Produits Nestle S.A. Composition comprising oligofructose (of) for use in the improvement of short term memory and other cognitive benefits
BR112019028039A2 (pt) * 2017-06-30 2020-07-07 N.V. Nutricia composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hiperinsulinemia
EP3672600A4 (en) 2017-08-21 2021-05-19 Glycom A/S SYNTHETIC COMPOSITION TO REDUCE ALLERGY SYMPTOMS
CN108823125A (zh) * 2018-06-13 2018-11-16 山东巴元生物科技有限公司 一种治疗睡眠障碍益生菌制剂的生产方法及应用
CN112888317A (zh) * 2018-08-08 2021-06-01 马斯公司 含低聚糖的宠物食品及使用方法
EP3897678A1 (en) * 2018-12-21 2021-10-27 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
CN113423288A (zh) * 2019-02-04 2021-09-21 N·V·努特里奇亚 用于睡眠改善的含有不可消化的低聚糖的发酵配方物
KR102188765B1 (ko) * 2019-06-12 2020-12-08 정옥숙 애완동물용 동결건조파우더 및 이의 제조방법
WO2021105353A1 (en) * 2019-11-29 2021-06-03 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CN112868800A (zh) * 2019-11-29 2021-06-01 内蒙古伊利实业集团股份有限公司 含母乳低聚糖提高免疫力的婴幼儿配方奶粉及其制备方法
EP4408198A1 (en) * 2021-09-28 2024-08-07 Société des Produits Nestlé S.A. Compositions for use
US12527342B2 (en) * 2024-01-12 2026-01-20 Nutifood Nutrition Food Joint Stock Company Supplementary composition containing 2′-fucosyllactose (2′-fl) and fructo-oligosaccharide (FOS) with synergistic effects on the digestive and immune systems for children, and process of manufacturing a children formula containing said supplementary composition

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3936799C1 (https=) * 1989-11-04 1991-01-10 Deutsche Atochem Werke Gmbh, 5300 Bonn, De
FR2714574B1 (fr) * 1993-12-31 1996-03-15 Inst Rech Biolog Sa Nouveaux suppléments alimentaires pour la nutrition des très jeunes enfants.
CA2458936A1 (en) * 2001-08-31 2003-03-13 Nutricopia, Inc. Nutritional frozen dessert and methods of menufacture
ES2326481T3 (es) * 2003-06-23 2009-10-13 Nestec S.A. Formula para recien nacidos o formula de continuacion.
RU2346449C2 (ru) * 2003-06-23 2009-02-20 Нестек С.А. Смесь для детей первых месяцев жизни или старше
WO2005035557A2 (en) * 2003-10-14 2005-04-21 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth, Near Dublin Adenylate cyclase in the treatment and/or prophylaxis of immune-medicated disease
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
AU2006217160B2 (en) * 2005-02-28 2011-09-15 N.V. Nutricia Nutritional composition with probiotics
US20060251634A1 (en) * 2005-05-06 2006-11-09 Ho-Jin Kang Method of improving immune function in mammals using lactobacillus strains with certain lipids
US20070059297A1 (en) * 2005-08-04 2007-03-15 Nestec, S.A. Methods and compositions for improving visual acuity
PT1940248E (pt) * 2005-10-05 2010-01-26 Nestec Sa Utilização de uma composição nutricional para promoção do crescimento acelerado
JP5264702B2 (ja) * 2006-03-29 2013-08-14 ネステク ソシエテ アノニム プロバイオティクスを含有する栄養補助食品
US7374924B2 (en) 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP1974743A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics to Improve Gut Microbiota
US20090118228A1 (en) * 2007-11-07 2009-05-07 Bristol-Myers Squibb Company Carotenoid-containing compositions and methods
BRPI0820802A2 (pt) * 2007-12-17 2015-06-16 Univ Florida Materiais e métodos para tratamento de proliferação vascular ocular patológica
EP3011843A1 (en) * 2008-09-19 2016-04-27 Nestec S.A. Nutritional support of the immune system during anti-cancer treatment

Also Published As

Publication number Publication date
IN2012DN00282A (https=) 2015-05-08
AU2010277582A1 (en) 2012-02-02
CA2767960A1 (en) 2011-02-03
CL2012000234A1 (es) 2012-09-28
EP2459202A1 (en) 2012-06-06
BR112012002223A2 (pt) 2016-06-07
CN102481323A (zh) 2012-05-30
WO2011012655A1 (en) 2011-02-03
MX2012001362A (es) 2012-02-22
SG177541A1 (en) 2012-02-28
RU2012107695A (ru) 2013-09-10
TW201117818A (en) 2011-06-01
US20120121562A1 (en) 2012-05-17

Similar Documents

Publication Publication Date Title
ZA201201471B (en) Nutritional compositions for breast-fed infants or pets with probiotics and selected nutrients
PL2429557T3 (pl) Preparaty do odżywiania niemowląt zawierające probiotyczne mikroorganizmy
ZA201201407B (en) Nutritional compositions comprising fiber and probiotics
ZA201203668B (en) Pet food compositions including probiotics and methods of manufacturing and use thereof
PL2323494T3 (pl) Produkty probiotyczne dla niemowląt
PL2323493T3 (pl) Produkty probiotyczne dla niemowląt
GB2448400A8 (en) Highchair with detachable infant carrier
IL225887A0 (en) Age-adjusted formula with caloric density especially for young toddlers
ZA201004529B (en) Age-tailored nutrition system for infants
EP2222264A4 (en) VACUUM ARTICLE WITH VENTED TOP
SG176642A1 (en) Nutritional composition for supporting brain development and function of toddlers
ZA201304086B (en) Pet food preparations containing probiotic micro-organisms
EP2460446A4 (en) DEVICE FOR TRANSPORTING FOOD AND BEVERAGE
PL2707478T3 (pl) Probiotyczne szczepy bakterii i zawierająca je kompozycja symbiotyczna przeznaczona do żywności dla niemowląt
EP2387920A4 (en) DEVICE FOR TRANSPORTING FOOD AND DRINKS
PT2418969E (pt) Nutrição para bebés anti-refluxo
EP2460445A4 (en) CONVEYING DEVICE FOR FOOD AND BEVERAGES
EP2461680A4 (en) NUTRITIONAL SUPPLEMENTS
IL226463A0 (en) An improved nutritional compound, especially for babies, with special fat particles
IL225535A0 (en) Age-adjusted nutritional formula especially with processed caloric concentration for babies and children
EP2460447A4 (en) DEVICE FOR TRANSPORTING FOOD AND BEVERAGE
EP2387919A4 (en) CONVEYING DEVICE FOR FOOD AND BEVERAGES
ZA201103689B (en) Nutritional composition with anti-regurgitation properties
PL2509431T3 (pl) Zrównoważona kompozycja tłuszczowa i jej zastosowanie w płynnej kompozycji żywieniowej odpowiedniej do żywienia dojelitowego
EP2519518A4 (en) DICHLOROACETATE OF IMATINIB AND ANTICANCER AGENT COMPRISING IT